All In Biotech

Drug Trial Radar · NCT03711162

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of GLPG1690 in Addition to Local Standard of Care for Minimum 52 Weeks in Subjects With Idiopathic Pulmonary Fibrosis

Last checked: Nov 20, 2026Latest source record: Jul 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 525 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

525

Actual

Start

Nov 28, 2018

Primary completion

Mar 30, 2021

Study completion Mar 30, 2021

Sponsor

Lead sponsor
Lakefront Biotherapeutics NVIndustry
Sponsor type
Industry
First posted
Oct 18, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study was to see how GLPG1690 works together with your current standard treatment on your lung function and IPF disease in general. The study also investigated how well GLPG1690 is tolerated (for example if you got any side effects while on study drug).

Conditions

  • Idiopathic Pulmonary Fibrosis

Interventions

  • GLPG1690Drug

    GLPG1690, film-coated tablets for oral use.

  • PlaceboDrug

    Matching placebo, film-coated tablets for oral use.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annual Rate of Decline in FVC up to Week 52Time frame: Baseline up to week 52

Locations

132 sites in 15 countries. Site status is shown where the registry gives one.

  • Pulmonary Associates

    Phoenix, Arizona

  • Mayo Clinic Arizona - PPDS

    Scottsdale, Arizona

  • Atria Clinical Research - BTC - PPDS

    Little Rock, Arkansas

  • David Geffen School of Medicine at UCLA

    Los Angeles, California

  • Respire Research

    Palm Springs, California

  • University of California San Diego

    San Diego, California

  • Stanford University Medical Center

    Stanford, California

  • University of Colorado

    Aurora, Colorado

  • National Jewish Health

    Denver, Colorado

  • Western Connecticut Medical Group

    Danbury, Connecticut

  • Yale University School of Medicine

    New Haven, Connecticut

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia

  • PAB Clinical Research - ClinEdge - PPDS

    Brandon, Florida

  • St. Francis Medical Institute - BTC - PPDS

    Clearwater, Florida

  • North Florida/South Georgia Veterans Health System-NAVREF-PPDS

    Gainesville, Florida

  • University of Florida

    Gainesville, Florida

  • Advanced Pulmonary Research Institute

    Loxahatchee Groves, Florida

  • Northwestern Memorial Hospital

    Chicago, Illinois

  • Pulmonary and Infections Disease Associates

    Council Bluffs, Iowa

  • University of Louisville

    Louisville, Kentucky

  • Tulane Medical Center

    New Orleans, Louisiana

  • University of Maryland Medical Center

    Baltimore, Maryland

  • Massachusetts General Hospital, Division of Pulmonary and Critical Care Medicine

    Boston, Massachusetts

  • Caritas St. Elizabeth's Medical Center

    Boston, Massachusetts

  • Henry Ford Health System

    Dearborn, Michigan

  • Minnesota Lung Center

    Minneapolis, Minnesota

  • Mayo Clinic - PPDS

    Rochester, Minnesota

  • Washington University School of Medicine

    St Louis, Missouri

  • Creighton University

    Omaha, Nebraska

  • University of Rochester Medical Center - PPDS

    Rochester, New York

  • PulmonIx LLC

    Greensboro, North Carolina

  • UC Health Department of Internal Medicine, Pulmonary, Critical Care & Sleep Medicine

    Cincinnati, Ohio

  • Cleveland Clinic

    Cleveland, Ohio

  • The Oregon Clinic

    Portland, Oregon

  • Penn State Milton S Hershey Medical Center

    Hershey, Pennsylvania

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • University of Texas Southwestern Medical Center

    Dallas, Texas

  • Houston Methodist Hospital

    Houston, Texas

Showing 40 of 132 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.